| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |